I agree with Good Investments and to add to that sometimes when your on a good thing you should stick to what you know.
I am all for corporate/business expansion but when your killing it with vitamins and minerals why create a generic brand of formula.
With all this said I think its fantastic news for A2m and Bellamys.
If Blackmores are successful with this release then A2M and Bellamys are going to fly seeing as though that are established and embedded in the Asian market. If they fail then nothing gained and nothing lost for A2m and BAL.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$7.22 |
Change
-0.070(0.96%) |
Mkt cap ! $5.227B | |||
| Open | High | Low | Value | Volume |
| $7.22 | $7.27 | $7.16 | $18.89M | 2.620M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3335 | $7.20 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.23 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 14/07/2025 (20 minute delay) ? |
| A2M (ASX) Chart |